Charles River Laboratories International (CRL) Net Income towards Common Stockholders (2009 - 2025)

Charles River Laboratories International (CRL) has reported Net Income towards Common Stockholders for 16 consecutive years, with -$276.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Net Income towards Common Stockholders fell 28.21% year-over-year to -$276.6 million; the TTM figure through Dec 2025 stood at -$144.3 million (down 1501.75% YoY), while the FY2025 annual figure was -$144.3 million, down 1501.75% from the prior year.
• Net Income towards Common Stockholders came in at -$276.6 million for Q4 2025 at Charles River Laboratories International, down from $54.4 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $189.1 million in Q4 2022, with the low at -$276.6 million in Q4 2025.
• Average Net Income towards Common Stockholders over 5 years is $61.6 million, with a median of $90.0 million recorded in 2021.
• Across the five-year window, Net Income towards Common Stockholders surged 48.94% in 2022 and tumbled 215.3% in 2024, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at $139.8 million in 2021, then surged by 35.24% to $189.1 million in 2022, then slipped by 1.07% to $187.1 million in 2023, then sank by 215.3% to -$215.7 million in 2024, then fell by 28.21% to -$276.6 million in 2025.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$276.6 million, $54.4 million, and $52.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.